Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 37% ± 13% | |
lung | 15 studies | 32% ± 11% | |
intestine | 11 studies | 30% ± 14% | |
kidney | 7 studies | 29% ± 10% | |
liver | 6 studies | 32% ± 20% | |
brain | 6 studies | 20% ± 3% | |
lymph node | 5 studies | 36% ± 5% | |
pancreas | 4 studies | 39% ± 7% | |
placenta | 4 studies | 33% ± 10% | |
bone marrow | 4 studies | 28% ± 7% | |
uterus | 4 studies | 43% ± 13% | |
breast | 4 studies | 38% ± 12% | |
eye | 3 studies | 25% ± 6% | |
prostate | 3 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10674.44 | 1445 / 1445 | 100% | 162.64 | 183 / 183 |
pancreas | 100% | 13115.91 | 328 / 328 | 100% | 173.95 | 178 / 178 |
prostate | 100% | 9744.56 | 245 / 245 | 100% | 239.30 | 502 / 502 |
skin | 100% | 15579.52 | 1809 / 1809 | 100% | 274.76 | 472 / 472 |
stomach | 100% | 9858.04 | 359 / 359 | 100% | 201.63 | 286 / 286 |
lung | 100% | 8922.50 | 578 / 578 | 100% | 197.26 | 1154 / 1155 |
thymus | 100% | 9187.46 | 653 / 653 | 100% | 226.75 | 604 / 605 |
intestine | 100% | 10105.60 | 966 / 966 | 100% | 234.87 | 526 / 527 |
uterus | 100% | 12275.28 | 170 / 170 | 100% | 200.96 | 458 / 459 |
kidney | 100% | 7697.55 | 89 / 89 | 100% | 154.93 | 899 / 901 |
ovary | 100% | 14191.16 | 180 / 180 | 100% | 161.63 | 429 / 430 |
breast | 100% | 12194.16 | 459 / 459 | 100% | 195.58 | 1115 / 1118 |
bladder | 100% | 11405.67 | 21 / 21 | 100% | 211.37 | 502 / 504 |
brain | 96% | 3756.35 | 2536 / 2642 | 100% | 143.61 | 705 / 705 |
adrenal gland | 100% | 8069.88 | 258 / 258 | 94% | 92.25 | 216 / 230 |
liver | 92% | 3240.31 | 208 / 226 | 99% | 125.44 | 402 / 406 |
adipose | 100% | 11323.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10509.60 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 320.60 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 333.15 | 29 / 29 |
spleen | 100% | 12885.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 221.46 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 134.26 | 1 / 1 |
muscle | 100% | 8273.40 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 10269.89 | 914 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 5309.74 | 828 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902416 | Biological process | positive regulation of mRNA binding |
GO_0001732 | Biological process | formation of cytoplasmic translation initiation complex |
GO_0075522 | Biological process | IRES-dependent viral translational initiation |
GO_0075525 | Biological process | viral translational termination-reinitiation |
GO_0006413 | Biological process | translational initiation |
GO_0002191 | Biological process | cap-dependent translational initiation |
GO_0045727 | Biological process | positive regulation of translation |
GO_0005852 | Cellular component | eukaryotic translation initiation factor 3 complex |
GO_0033290 | Cellular component | eukaryotic 48S preinitiation complex |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0071541 | Cellular component | eukaryotic translation initiation factor 3 complex, eIF3m |
GO_0016282 | Cellular component | eukaryotic 43S preinitiation complex |
GO_0016020 | Cellular component | membrane |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0098808 | Molecular function | mRNA cap binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF3D |
Protein name | Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66) Eukaryotic translation initiation factor 3 subunit D Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) |
Synonyms | EIF3S7 |
Description | FUNCTION: mRNA cap-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, a complex required for several steps in the initiation of protein synthesis of a specialized repertoire of mRNAs . The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation . The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression . In the eIF-3 complex, EIF3D specifically recognizes and binds the 7-methylguanosine cap of a subset of mRNAs . .; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 . . FUNCTION: mRNA cap-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, a complex required for several steps in the initiation of protein synthesis of a specialized repertoire of mRNAs. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. In the eIF-3 complex, EIF3D specifically recognizes and binds the 7-methylguanosine cap of a subset of mRNAs. . |
Accessions | A0A0D9SGB5 ENST00000402116.2 ENST00000455547.5 ENST00000216190.13 [O15371-1] ENST00000458572.1 B0QYA5 B4E1K8 B0QYA4 ENST00000405442.5 [O15371-1] B0QYA6 ENST00000478547.1 ENST00000457241.5 B0QYA8 O15371 |